NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device NanoPass Technologies Ltd. (“NanoPass”), a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for MicronJet®, its microneedle delivery device, with Janssen Pharmaceuticals, Inc. (JPI) for multiple vaccine fields.The license agreement … Continue reading NanoPass Technologies Ltd.